# LabIncube Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/labincube-co

- Industry: Medical Devices & Equipment
- Headquarters: Cheongju-si, South Korea
- Website: www.labincube.com/
- Total disclosed funding: $14M
- Latest round: Series B (Mar 18, 2026)
- Investors on record: 7

## About

Based in Chungju, South Korea, and founded in 2021, LabInCube manufactures metal-organic frameworks to control the absorption, protection, and release of target substances by adjusting molecular spacing. In March 2026, LabIncube Co., Ltd. raised KRW 17.4 billion in series B funding from new investor Metabiomed, with participation from returning investors BNH Investment, Union Investment Partners, and JKP Partners. As of March 2026, the company is led by CEO Kyung-min Choi.

LabInCube's core technology, InCube, is a drug delivery platform designed to facilitate extended lifespans. InCube utilizes molecular spacing control and slow-release technology to ensure minimal denaturation of substances during distribution and storage, enabling sustained release characteristics post-administration. The technology minimizes this denaturation by employing a warehouse-type drug storage platform that optimizes the spacing and environment of drug molecules. 

The company will use the March 2026 funding to advance its metal-organic framework–based materials platform and accelerate global commercialization.

## Funding rounds

- Series B, Mar 18, 2026, $9.9M — Union Investment Partners, BNH Investment, JKP Partners, Metabiomed
- Series A, Apr 2, 2024, $3.8M — Korea Investment Partners, Union Investment Partners, BNH Investment
- Seed, Mar 1, 2022 — Korea Tech Incubator for Startup, Yonsei Technology Holdings

## Investors

- Korea Tech Incubator for Startup — Seed
- Yonsei Technology Holdings (https://capitalatlas.ai/funds/yonsei-technology-holdings) — Seed
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A
- Union Investment Partners (https://capitalatlas.ai/funds/union-investment-partners) — Series A, Series B
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series A, Series B
- JKP Partners (https://capitalatlas.ai/funds/jkp-partners) — Series B
- Metabiomed — Series B